MEMBER SIGN IN
Not a member? Become one today!
         iBerkshires     Southern Berkshire Chamber     Lee Chamber     Lenox Chamber     Berkshire Community College    
Search
Home About Archives RSS Feed
The Retired Investor: IRS Incentive Boosts for Savers Not Nearly Enough
By Bill Schmick,
04:25PM / Thursday, January 02, 2025
Saving for retirement will get a little more attractive next year. Given the dire state of savings in this country, anything that convinces workers they need to save more will be beneficial.   The Secure Act 2.0, enacted in 2022, ushered in several additional improvements in retirement savings, including even higher 401(k) plan catch-up contributions. The object was to make it easier for older American workers facing a retirement savings shortfall to set aside more money quickly.    The facts are that there is a widespread retirement savings shortfall in the U.S. that spans generations. Sixty-five percent of Baby Boomers (age 55-64) have less than $25,000

0 Comments
Read More >>

The Retired Investor: The Billionaire Trump team
By Bill Schmick,
04:15PM / Thursday, December 26, 2024
Last week, billionaire Stephen Feinberg of the private equity firm Cerberus Capital Management was selected to fill the No. 2 spot at the Defense Department. That brings the number of billionaires who have agreed to join Donald Trump's second term to an even dozen. Should you be worried?   The wealth and business background of these individuals have sparked concerns that the next four years will favor business interests and those of the wealthy above all else. If we include Trump, Elon Musk, and Vivek Ramaswamy, the total thus far would be 15. At last count, U.S. News and World Report estimated that the total net worth of these billionaires as of Dec. 10 was more than

0 Comments
Read More >>

The Retired Investor: Trump's 21st Century Mercantilism
By Bill Schmick,
03:32PM / Friday, December 20, 2024
  Jan. 20 is just around the corner. It is Day One in the tariff wars that our next president is intent on launching. The corporate world is trying to dissuade him from that course of action, with no success.    It is an economic fact that the cost of tariffs is passed on to the consumer. If tariffs are high enough, some imported products simply cease to be available, which can cause supply chain interruptions. At some point, buyers balk at paying higher prices. When that happens, tariff costs hit business profit margins directly. Everyone loses.   In the last column, I explained why Donald Trump is adamant that tariffs are the only way to turn

0 Comments
Read More >>

The Retired Investor: Is Mercantilism the Answer to Our Trade Imbalance?
By Bill Schmick,
04:33PM / Thursday, December 12, 2024
Mercantilism is often associated with Donald Trump's economic policies. Can reaching back into the past truly make America great again? That is up for debate.   For those few of us familiar with the term, mercantilism was the dominant economic system in Europe from the 16th to the 18th centuries. It was a world where it was believed that global wealth was fixed and finite. To become powerful, a nation needed to acquire as much wealth as possible. Back then, a nation's wealth was measured by how much gold and silver it accumulated.   If this period evokes visions of tall ships, the Spanish Main, and epic exchanges of cannon fire between Spanish galleys

0 Comments
Read More >>

The Retired Investor: The Future of Weight Loss
By Bill Schmick,
04:27PM / Thursday, December 05, 2024
More than 40 percent of Americans are now classified as obese while 75 percent of adults are either overweight or obese. A new group of drugs called GLP-1 receptor agonists have come on the scene to help in the battle to lose weight. Are they as good as we think?   You may have heard about them or some of their brand names like Zepbound, Wegovy, and Ozempic. The use of these drugs has exploded in popularity to the point where companies like Lilly and Novo Nordisk have had problems keeping up with demand.    There is nothing magical about the science behind these drugs. GLP-1 mimics a protein naturally produced by our small intestines. The receptors for

0 Comments
Read More >>

NorthAdams.com is owned and operated by: Boxcar Media 106 Main Sreet, P.O. Box 1787 North Adams, MA 01247 -- T. 413-663-3384 F.413-663-3615
© 2008 Boxcar Media LLC - All rights reserved